BPC-157 is commonly described in databases and literature as a synthetic pentadecapeptide associated with the molecular formula C62H98N16O22 and PubChem CID 9941957 [1]
This combination runs for 6 to 8 weeks minimum
The significance of this paper is not only to compare the three routes of administration but also to evaluate them and determine which route is the best to administrate the drug
Green R, Allen LH, Bjrke-Monsen AL, Brito A, Guant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH et al
It appears to modulate neurotransmitter systems, including dopamine and serotonin, and has shown efficacy in counteracting damage induced by various neurotoxins, suggesting potential applications in neurological conditions like Parkinson's disease and schizophrenia-like models